Healthcare & Life Sciences marketing
Pipeline From Health Systems That Take A Year To Decide
For medical device manufacturers, diagnostics, digital health and life-sciences companies selling into hospitals, health systems, GPOs and payers.
Who this is for
Built For Healthcare & Life Sciences
Medical device OEMs, diagnostics and digital health companies whose sales are approved by a clinical committee, a value-analysis committee, procurement, IT and compliance — where the evidence matters more than the pitch.
How these buyers actually buy
The Committee, And The Cycle It Runs On
Twelve to twenty-four months is common, and a clinical champion alone cannot approve anything. Evidence is gathered long before a vendor conversation, and everything published is read as a claim — so regulatory review is part of the marketing process, not an obstacle to it.
Clinical champion
“Does this improve outcomes for my patients?”
Value analysis committee
“Is the clinical and economic evidence strong enough?”
Procurement / GPO
“Is it on contract, and what does it displace?”
IT & security
“How does it integrate, and where does the data live?”
Compliance / regulatory
“Can every claim here be substantiated?”
Finance
“Total cost, reimbursement and payback.”
Why it works
What A Named-Account Programme Changes
Evidence, not adjectives
Clinical and economic substance that survives a value-analysis review — because that is the committee that actually says yes or no.
Reach past the champion
Deals die when the clinician is enthusiastic and procurement, IT and compliance have never heard of you.
Compliant by construction
Claims are scoped and reviewed before publication, so nothing has to be pulled down later.
The problems we solve
Named, Not Generic
Your champion cannot get it through value analysis
Enthusiasm at the clinical level is not evidence. Without the economic case in a form the committee reviews, the deal stops there.
Compliance kills the campaign at the last step
Marketing written first and reviewed later gets rewritten into nothing. Building inside the constraints from the start produces material that ships.
Nobody in IT or procurement knows who you are
Two of the people who can block the deal are meeting you for the first time during evaluation.
The cycle outlasts the reporting
When a deal takes eighteen months, quarterly lead reports say nothing. Account-level reporting shows movement while it is happening.
The system
How The System Works For You
Name the accounts, not the market
A tiered target account list built on real fit criteria and signed off by the sales team who have to work it — so budget goes at companies that can actually buy at your size.
Reach the whole buying committee
Six to ten people sign off on a serious purchase and most of them will never fill in a form. Each role gets the answer to the question they personally own.
Publish the detail the evaluators need
Technical, regulatory and commercial substance that stands up to scrutiny — because in a considered purchase the evaluation happens before anyone contacts you.
Support the deal after the enquiry
Long cycles stall between the first conversation and the signature. We build the content and air cover that keeps a live deal moving through review, procurement and approval.
Report pipeline, not activity
Account coverage, committee reach, pipeline created and influenced, velocity and win rate — with the attribution window stated.
The services behind this: account-based marketing for the programme, LinkedIn Ads for reaching the committee inside named accounts, and CRM systems so coverage and pipeline are measurable rather than asserted — and where the account list has to be sourced and enriched at scale, a custom lead database underneath all of it.
Our methodology
The Account Engine
Every account-based programme we run moves through the same six stages, in the same order. It is the reason two different clients get the same rigour rather than whatever their strategist happened to prefer.
01 · Objective
The number the programme is judged on, the motion that gets there, and who owns each part. Agreed with sales and finance before anything is built.
02 · ICP
Firmographic, technographic and behavioural definition of accounts that can buy at your size and expand afterwards — not everyone who could theoretically use the product.
03 · Target accounts
A finite target account list, tiered 1:1 / 1:few / 1:many by what each account is worth, scored for fit and signed off by sales.
04 · Value proposition
What changes for the economic buyer, the champion, the technical evaluator and the blocker — each answered separately, because they are asking different questions.
05 · Playbooks
The channels, content and sequences that run against each tier, with entry and exit criteria so a play either earns its place or stops.
06 · Delivery & measurement
Account coverage, buying-committee reach, pipeline created and influenced, velocity and win rate — reported with the attribution window stated.
Straight answers
Healthcare & Life Sciences Marketing FAQ
Including the one about whether we have done this before.
Have you worked with healthcare & life sciences companies before?
Our published client work is Ontario trades, retail, hospitality and e-commerce — we are not going to claim a healthcare & life sciences portfolio we have not published. What transfers is the account-based discipline on this page, an in-house production crew, and paid media measured against pipeline rather than clicks. On the call we will tell you honestly whether your situation needs a specialist we cannot be.
How is this different from lead generation?
Lead generation optimises for volume of enquiries. A named-account programme starts from a finite list of companies worth winning and measures account coverage, buying-committee reach and pipeline. When the deal is large and the committee is six people, counting form fills tells you almost nothing.
What does it cost and how does it start?
Most engagements start with a paid diagnostic — a short, fixed-scope assessment of your ICP, target account list, committee coverage and reporting, ending in a written plan you own either way. Ongoing work is scoped and quoted plainly; there is no package tier and no public price list.
How long before we see pipeline?
Engagement signals — accounts moving from cold to active, more committee members reached — typically appear in 4 to 8 weeks. Pipeline follows your existing cycle, so on a twelve-month capital sale that is when revenue lands. Anyone promising closed enterprise deals in month one is describing something else.
Book A Call About Your Healthcare & Life Sciences Pipeline
Bring your target account list, your average deal size and your sales cycle. You'll leave with a written view of what to run first — hire us or not.
You'll talk to Cruz or Keegan — not a sales rep. Leave your strategy call with a written growth plan — yours to keep, hire us or not.